Chelsee Jensen, PharmD, senior pharmacy specialist at Mayo Clinic, talks about the importance of patient, provider, and nursing education as the US biosimilars landscape evolves.
It's important for pharmacists to have advanced conversations so they are prepared for the launch of new and expanded biosimilars, said Chelsee Jensen, PharmD, senior pharmacy specialist at Mayo Clinic during the Academy of Managed Care Pharmacy Nexus 2022 fall meeting.
Transcript
How can stakeholders promote a competitive landscape that continues to encourage biosimilar uptake within their organizations?
I think from a health system perspective, it's really going to be important to continue to have conversations with payers and also to share what kind of savings have been passed through to payers through adoption of biosimilars. I think that will really help smooth conversations to continue biosimilar utilization and promote biosimilar use across the US.
What considerations should payers, providers, and pharmacists keep in mind as biosimilars expand into new therapeutic areas?
I really think this is going to come down to education. Especially as we expand into new therapeutic areas, it's important for pharmacists, nurses, providers to be aware of, again, what indications. If they're skinny label indications that biosimilars do not carry, to be aware of that, as well as to understand if the plan is going to cover those off-label indications or not. And again, if there are formulation differences that are occurring, just to have those discussions with patients far in advance so they are prepared for changes and prepared to adopt a biosimilar without having any risk for the nocebo effect.
As the industry awaits for adalimumab biosimilars to enter the market next year, what can health systems do now to ensure these products stand the best chance against the originator?
At our AMCP session, "The Evolving US Biosimilars Landscape," I think one of the important points of emphasis is, again, patient education, provider education, nursing education. As the as we transition to this, there's going to be huge impact obviously on the pharmacy benefit. I think there is going to be less operational hurdles with real-time benefit checks. However, again, as we prepare for formulation changes or delivery device changes, it's important to educate patients so they're well-informed. At a pharmacy level, again, to be prepped for those inventory changes if you need to purchase additional refrigerators or maybe downsize if possible, just to have advanced conversation so you're well prepared for those to launch.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
A new federal rule will enable thousands of immigrants in the Deferred Action for Childhood Arrivals (DACA) program to obtain health care through the Affordable Care Act; a forthcoming CMS rule is expected to lower home-based care wait times and raise caregiver wages; the HHS Office for Civil Rights has finalized 2 rules that strengthen the ACA’s health care discrimination ban.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Initiating BP Medication Linked to Higher Fall, Fracture Risks in Nursing Home Residents
May 2nd 2024Among over 60,000 nursing home residents who initiated antihypertensive medication, rates of excess fractures due to falls per 100 person-years were as high as 5 among certain patient groups, such as those with dementia and high blood pressure (BP).
Read More